Iniciar sesión

Esther Hulleman

Amsterdam UMC,
Vrije Universiteit Amsterdam,
Pediatric Oncology,
Amsterdam UMC, Vrije Universiteit Amsterdam, Pediatric Oncology

Cancer Center Amsterdam

BIOGRAPHY

Esther Hulleman has not added Biography.

If you are Esther Hulleman and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis.

Oncotarget Dec, 2010 | Pubmed ID: 21321380

Blood platelets contain tumor-derived RNA biomarkers.

Blood Sep, 2011 | Pubmed ID: 21832279

PARP inhibition sensitizes childhood high grade glioma, medulloblastoma and ependymoma to radiation.

Oncotarget Dec, 2011 | Pubmed ID: 22184287

EZH2-regulated DAB2IP is a medulloblastoma tumor suppressor and a positive marker for survival.

Clinical cancer research : an official journal of the American Association for Cancer Research Aug, 2012 | Pubmed ID: 22696229

EphB2 activity plays a pivotal role in pediatric medulloblastoma cell adhesion and invasion.

Neuro-oncology Sep, 2012 | Pubmed ID: 22723427

EFEMP1 induces γ-secretase/Notch-mediated temozolomide resistance in glioblastoma.

Oncotarget Jan, 2014 | Pubmed ID: 24495907

Identification of temozolomide resistance factors in glioblastoma via integrative miRNA/mRNA regulatory network analysis.

Scientific reports Jun, 2014 | Pubmed ID: 24919120

A dual program for translation regulation in cellular proliferation and differentiation.

Cell Sep, 2014 | Pubmed ID: 25215487

Functionally defined therapeutic targets in diffuse intrinsic pontine glioma.

Nature medicine Jun, 2015 | Pubmed ID: 25939062

A chemical screen for medulloblastoma identifies quercetin as a putative radiosensitizer.

Oncotarget Jun, 2016 | Pubmed ID: 26967057

Multiregional tumor drug-uptake imaging by PET and microvascular morphology in end-stage diffuse intrinsic pontine glioma.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine Aug, 2017 | Pubmed ID: 28818988

Culture methods of diffuse intrinsic pontine glioma cells determine response to targeted therapies.

Experimental cell research 11, 2017 | Pubmed ID: 28947132

Deceptive morphologic and epigenetic heterogeneity in diffuse intrinsic pontine glioma.

Oncotarget 09, 2017 | Pubmed ID: 28947983

Signaling pathways and mesenchymal transition in pediatric high-grade glioma.

Cellular and molecular life sciences : CMLS Mar, 2018 | Pubmed ID: 29164272

Identification of Two Protein-Signaling States Delineating Transcriptionally Heterogeneous Human Medulloblastoma.

Cell reports 03, 2018 | Pubmed ID: 29562177

IL-13 receptors as possible therapeutic targets in diffuse intrinsic pontine glioma.

PloS one , 2018 | Pubmed ID: 29621254

MELK Inhibition in Diffuse Intrinsic Pontine Glioma.

Clinical cancer research : an official journal of the American Association for Cancer Research 11, 2018 | Pubmed ID: 30061363

An efficient method for the transduction of primary pediatric glioma neurospheres.

MethodsX , 2018 | Pubmed ID: 30622915

Preclinical therapeutic targets in diffuse midline glioma.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 05, 2019 | Pubmed ID: 31202081

MEK/MELK inhibition and blood-brain barrier deficiencies in atypical teratoid/rhabdoid tumors.

Neuro-oncology 01, 2020 | Pubmed ID: 31504799

Celastrol-induced degradation of FANCD2 sensitizes pediatric high-grade gliomas to the DNA-crosslinking agent carboplatin.

EBioMedicine Dec, 2019 | Pubmed ID: 31735550

Patient-Derived Orthotopic Xenograft Models of Pediatric Brain Tumors: In a Mature Phase or Still in Its Infancy?

Frontiers in oncology , 2019 | Pubmed ID: 31970083

Combined Therapy of AXL and HDAC Inhibition Reverses Mesenchymal Transition in Diffuse Intrinsic Pontine Glioma.

Clinical cancer research : an official journal of the American Association for Cancer Research Jul, 2020 | Pubmed ID: 32165429

Development of transient radioresistance during fractionated irradiation in vitro.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology Apr, 2020 | Pubmed ID: 32344261

INSTITUTIONS

Cancer Center Amsterdam

Princess Máxima Center for Pediatric Oncology

JOVE ARTICLES

A High-Throughput Image-Guided Stereotactic Neuronavigation and Focused Ultrasound System for Blood-Brain Barrier Opening in Rodents

Rianne Haumann^*,1,2,

Elvin ’t Hart^*,2,

Marc P. P. Derieppe²,

Helena C. Besse³,

Gertjan J. L. Kaspers^1,2,

Eelco Hoving²,

Dannis G. van Vuurden^1,2,

Esther Hulleman^1,2,

Mario Ries³

¹Amsterdam UMC, Vrije Universiteit Amsterdam, Pediatric Oncology, Cancer Center Amsterdam,

², Princess Máxima Center for Pediatric Oncology,

³Imaging Division, Utrecht University

Neuroscience

Privacidad

Condiciones de uso

Políticas

Contáctenos

RECOMIENDE A LA BIBLIOTECA

BOLETINES de JoVE

Investigación

JoVE Journal
Colecciones de métodos
JoVE Encyclopedia of Experiments
Archivo

Educación

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centro de recursos académicos
Faculty Site

Autores

Descripción
Proceso de publicación
Comité editorial
Ámbito y políticas
Revisión por pares
Preguntas frecuentes
Enviar

Bibliotecarios

Descripción
Testimonios
Suscripciones
Acceso
Recursos
Junta Asesora de Bibliotecarios
Preguntas frecuentes

ACERCA DE JoVE

Descripción
Liderazgo
Blog
JoVE Help Center

Esther Hulleman

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Amsterdam UMC,Vrije Universiteit Amsterdam,Pediatric Oncology,Amsterdam UMC, Vrije Universiteit Amsterdam, Pediatric Oncology

Cancer Center Amsterdam

A High-Throughput Image-Guided Stereotactic Neuronavigation and Focused Ultrasound System for Blood-Brain Barrier Opening in Rodents

Amsterdam UMC,
Vrije Universiteit Amsterdam,
Pediatric Oncology,
Amsterdam UMC, Vrije Universiteit Amsterdam, Pediatric Oncology